CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

Michael C. Fahey

OPENALEX: A5013570044↗ORCID: 0000-0003-0811-4785↗

Affiliations

Organizations

Monash Children’s Hospitalauthorship · AU Monash Healthauthorship · AU

Public evidence

2 connected articles

Safety and efficacy of orally administered full-spectrum medicinal cannabis plant extract 0.08% THC (NTI-164) in children with autism spectrum disorder: An open-label study.2023 · medRxiv Medicinal cannabis plant extract (NTI164) modifies epigenetic, ribosomal, and immune pathways in paediatric acute-onset neuropsychiatric syndrome.2026 · Europe PMC

Matched by exact identifiers only. Profile data: Corpus/OpenAlex.

Michael C. Fahey - Medical Cannabis Research Engine